SCHEMBL18474336

SCHEMBL18474336

Cc1[nH]c2ccc(Cl)cc2c1C1CCCCC1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 3/20 0.71
OPRK1 P41145 3/20 0.71
OPRD1 P41143 2/20 0.71
OPRL1 P41146 2/20 0.71
CSF1R P07333 1/20 0.56
EIF2AK2 P19525 1/20 0.46
PTGS2 P35354 1/20 0.45
HTR2A P28223 3/20 0.44
HTR2C P28335 3/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
ALDH1A1 P00352 1/20 0.44
POLB P06746 1/20 0.44
LMNA P02545 1/20 0.44
HTR6 P50406 4/20 0.43
HTR7 P34969 2/20 0.43
ADRA2A P08913 1/20 0.43
ADRA2B P18089 1/20 0.43
ADRA2C P18825 1/20 0.43
HTR2B P41595 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4766493 0.87 OPRM1 (0.59) OPRM1OPRK1OPRD1OPRL1CSF1R
SCHEMBL14280684 0.84 OPRM1 (1.00) OPRM1OPRK1OPRD1OPRL1CSF1R
SCHEMBL18440866 0.84 OPRM1 (0.54) OPRM1OPRK1OPRD1OPRL1CSF1R
SCHEMBL18441308 0.83 OPRM1 (0.53) OPRM1OPRK1OPRD1OPRL1CSF1R
Acetic Acid SCHEMBL11875354 0.80 OPRM1 (0.53) OPRM1OPRK1OPRD1OPRL1CSF1R
SCHEMBL8726509 0.78 LMNA (0.51) OPRM1OPRK1OPRD1OPRL1HTR2A
SCHEMBL4774609 0.74 OPRM1 (0.54) OPRM1OPRK1OPRD1OPRL1MEN1
SCHEMBL13809832 0.73 OPRM1 (0.41) OPRM1OPRK1OPRD1OPRL1CSF1R
SCHEMBL4849368 0.73 CSF1R (1.00) OPRM1OPRK1OPRD1OPRL1CSF1R
SCHEMBL4844308 0.73 CSF1R (1.00) OPRM1OPRK1OPRD1OPRL1CSF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017023894-A1 MTHFD2 INHIBITORS AND USES THEREOF RAZE THERAPEUTICS, INC. (US) 2017-02-09 WO disclosed